M&A: Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

What You Should Know: – Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology. – The acquisition, valued at $81.25M, paid predominantly in Tempus common stock, is a strategic move to grow Tempus’s dataset, expand its technical team, and strengthen its ... Read More